NASDAQ · AVRHealthcareOrthopedic & Surgical Supplies

Anteris Technologies Global financials

$7.59−1.94%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$1.9M$2.7M
Gross profit$1.3M$1.3M
Gross margin70.3%46.8%
Operating income-$93.9M-$78.4M
Net income-$94.1M-$76.3M
Net margin−4921.3%−2822.5%
Diluted EPS$-2.55$-3.68
EBITDA-$92.2M-$76.9M
Operating cash flow-$77.8M-$61.2M
Free cash flow-$79.8M-$63.5M
Diluted shares36.9M20.3M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$12.6M$70.5M
Short-term investments$0.00$0.00
Total debt$38.0K$3.0K
Total assets$23.0M$80.7M
Total liabilities$23.3M$18.0M
Shareholders' equity-$253.0K$62.7M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology